PRTA - Prothena Corporation plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
58.83
-1.53 (-2.53%)
As of 3:23PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close60.36
Open59.94
Bid58.92 x 100
Ask59.13 x 100
Day's Range58.56 - 60.51
52 Week Range40.58 - 70.00
Volume104,014
Avg. Volume232,144
Market Cap2.25B
Beta3.28
PE Ratio (TTM)-14.47
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Carson Block Shorts Prothena on Drug Questions
    Bloomberg Video4 months ago

    Carson Block Shorts Prothena on Drug Questions

    Jun.29 -- Carson Block, chief investment officer and founder at Muddy Waters Capital, explains why he shorted the stock of Prothena Corp. Plc. He speaks with Bloomberg's Julia Chatterley on "Bloomberg Markets."

  • Capital Cube3 days ago

    Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : October 16, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Prothena Corp. Plc a score of 14. Our analysis is based on comparing Prothena Corp. Plc with the following peers – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US). Investment Outlook Prothena ... Read more (Read more...)

  • Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : October 13, 2017
    Capital Cube6 days ago

    Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : October 13, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Prothena's Psoriasis Candidate Disappoints in Phase I Study
    Zacks17 days ago

    Prothena's Psoriasis Candidate Disappoints in Phase I Study

    Prothena Corporation plc (PRTA) announced disappointing results from a phase Ib study of pipeline candidate, PRX003 in psoriasis patients.

  • MarketWatch20 days ago

    Biotech Prothena shares fall after it scraps psoriasis trial

    Shares of biotech Prothena Corp. Plc slid 3.3% Friday, after the company said it was scrapping a psoriasis treatment after a trial failed to show the effects the company was seeking. Dublin-based Prothena ...

  • TheStreet.com20 days ago

    Zogenix Soars After Epilepsy Drug Meets Primary Endpoint -Biotech Movers

    The Emeryville, Calif.-based firm said its first Phase 3 study of ZX008 in Dravet syndrome achieved its primary endpoint. Dravet syndrome is a form of epilepsy.

  • Stocks To Watch: Prothena Sees Relative Strength Rating Jump To 81
    Investor's Business Daily22 days ago

    Stocks To Watch: Prothena Sees Relative Strength Rating Jump To 81

    Prothena shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.

  • Stocks Flashing Renewed Technical Strength: Prothena
    Investor's Business Dailylast month

    Stocks Flashing Renewed Technical Strength: Prothena

    A Relative Strength Rating upgrade for Prothena shows improving technical performance.

  • Capital Cubelast month

    ETFs with exposure to Prothena Corp. Plc : September 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Prothena Corp. Plc Here are 5 ETFs with the largest exposure to PRTA-US. Comparing the performance and risk of Prothena Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017
    Capital Cubelast month

    Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017

    Categories: Yahoo FinanceGet free summary analysis Prothena Corp. Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Prothena Corp. Plc – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US) that ... Read more (Read more...)

  • Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : September 1, 2017
    Capital Cube2 months ago

    Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : September 1, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • AstraZeneca and Takeda Ink Deal to Develop Parkinson's Drug
    Zacks2 months ago

    AstraZeneca and Takeda Ink Deal to Develop Parkinson's Drug

    AstraZeneca (AZN) and Takeda Pharmaceutical Company entered into an agreement to jointly develop and commercialize MEDI1341 for the potential treatment of Parkinson's disease.

  • Capital Cube2 months ago

    Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : August 23, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Prothena Corp. Plc a score of 14. Our analysis is based on comparing Prothena Corp. Plc with the following peers – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US). Investment Outlook Prothena ... Read more (Read more...)

  • Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : August 11, 2017
    Capital Cube2 months ago

    Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : August 11, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Prothena (PRTA) Q2 Loss Narrows as Roche Makes $30M Payment
    Zacks2 months ago

    Prothena (PRTA) Q2 Loss Narrows as Roche Makes $30M Payment

    Prothena Corporation plc (PRTA) reported a narrower-than-expected loss in the second quarter as the company received a milestone payment from Roche.

  • Associated Press2 months ago

    Prothena reports 2Q loss

    On a per-share basis, the Dun Laoghaire, Ireland-based company said it had a loss of 46 cents. The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment ...

  • Should You Buy Prothena Corporation PLC (PRTA) Ahead of Earnings?
    Zacks2 months ago

    Should You Buy Prothena Corporation PLC (PRTA) Ahead of Earnings?

    Given that Prothena Corporation PLC (PRTA) has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings.

  • Can Prothena (PRTA) Deliver a Beat this Earnings Season?
    Zacks3 months ago

    Can Prothena (PRTA) Deliver a Beat this Earnings Season?

    Prothena Corporation plc (PRTA) is expected to report second-quarter results next week and we expect investor focus on pipeline updates.

  • Benzinga4 months ago

    Muddy Waters Shorts Prothena On Doubts Of Drug Candidate's Efficacy

    Short-seller Muddy Waters Research has a new target for its cynical trade strategy. The firm’s Carson Block announced a short position in Prothena Corporation PLC (NASDAQ: PRTA ) Thursday on Bloomberg ...

  • Feared short seller Carson Block's next target is this biotech stock
    CNBC4 months ago

    Feared short seller Carson Block's next target is this biotech stock

    Muddy Waters' Carson Block posted a bearish report on Prothena.

  • Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : June 28, 2017
    Capital Cube4 months ago

    Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : June 28, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cube4 months ago

    Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : June 15, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Prothena Corp. Plc a score of 14. Our analysis is based on comparing Prothena Corp. Plc with the following peers – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US). Investment Outlook Prothena ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Prothena Corp. Plc : June 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Prothena Corp. Plc Here are 5 ETFs with the largest exposure to PRTA-US. Comparing the performance and risk of Prothena Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : June 14, 2017
    Capital Cube4 months ago

    Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : June 14, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Prothena (PRTA) Down 5.8% Since Earnings Report: Can It Rebound?
    Zacks4 months ago

    Prothena (PRTA) Down 5.8% Since Earnings Report: Can It Rebound?

    Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.